Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Zealand Pharma

280.50 DKK

-5.75 %

Less than 1K followers

ZEAL

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Zealand Pharma

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue4.49.162.78.19,088.349.668.99,214.9
EBITDA-349.4-399.3-1,272.2-407.08,338.4-461.3-483.36,986.8
EBIT-349.4-399.3-1,272.2-407.08,338.4-461.3-510.66,959.4
EBIT-%-7,905.2 %-4,411.9 %-2,029.4 %-5,030.1 %91.7 %-930.7 %-741.0 %75.5 %
Profit before taxes-267.8-291.6-1,083.5-336.78,111.0-366.7-406.57,001.1
Net income-266.4-291.0-1,078.8-335.37,573.7-404.2-379.16,455.0
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.